Biogen Inc
Pharmaceuticals
BIIB
$ 290 (0.63)%
Share price
$ 42 bn
Market Cap
$ 43 bn
Enterprise Value
Carbon footprint
Primary Climate Goal
Biogen Inc aims to reduce Scope 1 + 2 by 55% by 2032 from a base year 2019
1.5°C
GHG emissions and Carbon intensity
Biogen Inc reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 97 Kt (+2.9/+3.1% y-o-y). Carbon intensity also surged to 8.9 t (+1.9/+27% y-o-y).
Biogen Inc's Scope 3 emissions increased to 406 Kt (
The company is committed to reducing Scope 1 + 2 by 55% by 2032 from a base year 2019, which translates into the estimated reduction of -4.6 Kt per annum over the period of FY2022 - FY2032. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.
Copyright © 2023 Exerica. All rights reserved.